NanoArrayPAD−X: Nanoprobe Array and 3D-µPAD for the Simultaneous Detection of Respiratory Pathogens and Biomarkers at the Point of Care
Authors:
- Andreu VaquerAVAndreu Vaquer
- Francisco M. BouzadaFBFrancisco M. Bouzada
- Sofia TejadaSTSofia Tejada
- Antonio ClementeACAntonio Clemente
- Antonia SociasASAntonia Socias
- Maria ArandaMAMaria Aranda
- Alberto del CastilloACAlberto del Castillo
- Joana MenaJMJoana Mena
- Maria MontanerMMMaria Montaner
- Rocío RodríguezRRRocío Rodríguez
- Estrella Rojo-MolineroEREstrella Rojo-Molinero
- Antonio OliverAOAntonio Oliver
Open Access
- 28 October 2025
- journal article
- research article
- Published by MDPI AG in Biosensors
- Vol. 15 (11) , 715
Abstract
Microfluidic paper-based analytical devices (µPADs) are ideal for point-of-care diagnostics due to their low cost, compact size, and ease of use. However, current designs have limited multiplexing capabilities, making it difficult to simultaneously detect pathogens and biomarkers in the same sample. In this work, we introduce NanoArrayPAD−X, a novel µPAD design that combines wax-printed microfluidic networks with an array of nanoprobes for the simultaneous detection of multiple targets. This is achieved by distributing the sample through the microfluidic network containing X detection areas. There, targets are captured through physical interactions and recognized by specific antibody-coated nanoprobes released from the nanoprobe array. This generates X dots whose color depends on the concentration of the targets in the sample. A NanoArrayPAD−5 platform capable of detecting five targets was developed to aid in the diagnosis of ventilator-associated pneumonia (VAP). The sensor array could detect Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus, Escherichia coli, and the inflammatory biomarker myeloperoxidase (MPO) with a total turnaround time of 25 min, which is faster than waiting for an overnight culture and the results of an ELISA. Notably, our prototype successfully detected the targets in 87 bronchial aspirate (BAS) specimens, thus demonstrating the suitability of the platform for analyzing complex samples with sputum-like qualities. These findings establish NanoArrayPAD−X as a promising tool for the rapid, multiplexed screening of respiratory pathogens and biomarkers, with potential for guiding personalized antimicrobial therapy in suspected cases of nosocomial pneumonia.Keywords
This publication has 43 references indexed in Scilit:
- A multirange paper-based analytical device for identifying low, moderate, and high P. aeruginosa bacterial loads in sputum samplesBiosensors and Bioelectronics, 2024
- Thymine-capped mesoporous silica nanoparticles as ion-responsive release system: A paper-based colorimetric sensing platform for rapid and selective mercuric identificationBiosensors and Bioelectronics, 2024
- OriPlex: Origami-enabled multiplexed detection of respiratory pathogensBiosensors and Bioelectronics, 2024
- Management of Ventilator-Associated PneumoniaInfectious Disease Clinics of North America, 2024
- Key inflammatory markers in bronchoalveolar lavage predict bronchiectasis progression in young children with CFJournal of Cystic Fibrosis, 2024
- Evaluation of the clinical relevance of the Biofire© FilmArray pneumonia panel among hospitalized patientsInfection, 2023
- Induced sputum metabolomic profiles and oxidative stress are associated with chronic obstructive pulmonary disease (COPD) severity: potential use for predictive, preventive, and personalized medicineEPMA Journal, 2020
- Ventilator-associated pneumonia in adults: a narrative reviewIntensive Care Medicine, 2020
- Signal amplification strategies for paper-based analytical devicesBiosensors and Bioelectronics, 2019
- Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature reviewRespiratory Medicine, 2018